KalVista Pharmaceuticals, Inc. (KALV)
After hours:
| Previous Close | 11.25 |
| Open | 11.30 |
| Bid | 11.64 x 500 |
| Ask | 11.72 x 100 |
| Day's Range | 11.30 - 11.99 |
| 52 Week Range | 7.21 - 16.88 |
| Volume | |
| Avg. Volume | 437,742 |
| Market Cap | 492.337M |
| Beta (5Y Monthly) | 0.92 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.12 |
| Earnings Date | Jul 05, 2024 - Jul 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.80 |
Business WireKalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary Angioedema
CAMBRIDGE, Mass. & SALISBURY, England, May 31, 2024--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that late-breaking data from the pivotal phase 3 KONFIDENT trial and open label KONFIDENT-S extension trial evaluating the efficacy and safety of sebetralstat were presented as late-breaking presentations at the European Academy of Allergy and Clinical Immunology Congress 2024. The results of KONFIDENT were simultaneously published in The New England Journal of Medicine.
Business WireKalVista Pharmaceuticals Announces Ten Abstracts Accepted for Presentation at the European Academy of Allergy and Clinical Immunology Congress 2024
CAMBRIDGE, Mass. & SALISBURY, England, May 24, 2024--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the acceptance of multiple abstracts and a symposium at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024 taking place in Valencia, Spain from May 31-June 3.
Simply Wall St.Breakeven On The Horizon For KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)
KalVista Pharmaceuticals, Inc. ( NASDAQ:KALV ) is possibly approaching a major achievement in its business, so we would...
